{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "marketState": "PREPRE", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -0.4918033, "regularMarketPrice": 6070.0, "exchange": "KOE", "shortName": "SillaJen", "longName": "SillaJen, Inc.", "exchangeTimezoneName": "Asia/Seoul", "market": "kr_market", "regularMarketTime": 1683873029, "regularMarketDayHigh": 6120.0, "regularMarketDayRange": "5960.0 - 6120.0", "regularMarketDayLow": 5960.0, "regularMarketVolume": 689172, "regularMarketPreviousClose": 6100.0, "bid": 6070.0, "ask": 6080.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 6040.0, "averageDailyVolume3Month": 1672484, "averageDailyVolume10Day": 887687, "fiftyTwoWeekLowChange": 1020.0, "fiftyTwoWeekLowChangePercent": 0.2019802, "fiftyTwoWeekRange": "5050.0 - 16550.0", "fiftyTwoWeekHighChange": -10480.0, "fiftyTwoWeekHighChangePercent": -0.63323265, "fiftyTwoWeekLow": 5050.0, "fiftyTwoWeekHigh": 16550.0, "earningsTimestamp": 1679569140, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 70529104, "fiftyDayAverage": 5869.4, "fiftyDayAverageChange": 200.6001, "fiftyDayAverageChangePercent": 0.034177277, "twoHundredDayAverage": 7628.6987, "twoHundredDayAverageChange": -1558.6987, "twoHundredDayAverageChangePercent": -0.2043204, "marketCap": 428111659008, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1480982400000, "priceHint": 2, "regularMarketChange": -30.0, "symbol": "215600.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "O2 Tower", "address2": "11th Floor 83 Uisadang-daero Yeongdeungpo-gu", "city": "Seoul", "zip": "07325", "country": "South Korea", "phone": "82 2 368 2600", "fax": "82 2 783 7555", "website": "https://www.sillajen.com", "industry": "", "sector": "", "longBusinessSummary": "SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Eun-Sang  Moon M.D., DDS", "title": "Chairman & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Suk Song  Myung", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sung-Kuon  Chi Ph.D.", "age": 70, "title": "Chief Operating Officer and Exec. VP", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eun-Ki  Min", "title": "Chief Accounting Officer and Exec. Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sung-Jin  Yoon", "title": "Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Chan Kwon  Hyuk M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mee Yang  Kyung Ph.D.", "title": "Head of R&D Strategic Planning", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 9, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}